Compounds > aminosalicylic acid

aminosalicylic acid and bedaquiline

aminosalicylic acid has been researched along with bedaquiline in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Barry Rd, CE; Boshoff, HI; Copp, BR; Dalton, J; Phummarin, N; Tsang, PS; Wiles, S1
Caminero, JA; Migliori, GB; Piubello, A; Scardigli, A1
Ahmad, N; Baghaei, P; Barkane, L; Benedetti, A; Brode, SK; Brust, JCM; Campbell, JR; Chang, VWL; Falzon, D; Guglielmetti, L; Isaakidis, P; Kempker, RR; Kipiani, M; Kuksa, L; Lan, Z; Lange, C; Laniado-Laborín, R; Menzies, D; Nahid, P; Rodrigues, D; Singla, R; Udwadia, ZF1
Dhamija, RK; Garg, D; Saroha, D; Singh, AK1

Reviews

1 review(s) available for aminosalicylic acid and bedaquiline

ArticleYear
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    The Lancet. Respiratory medicine, 2020, Volume: 8, Issue:4

    Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Canada; Clofazimine; Diarylquinolines; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Incidence; Linezolid; Male; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2020

Other Studies

3 other study(ies) available for aminosalicylic acid and bedaquiline

ArticleYear
SAR and identification of 2-(quinolin-4-yloxy)acetamides as
    MedChemComm, 2016, Nov-01, Volume: 7, Issue:11

    Topics:

2016
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.
    The European respiratory journal, 2017, Volume: 50, Issue:1

    Topics: Aminosalicylic Acid; Antitubercular Agents; Carbapenems; Clofazimine; Communicable Disease Control; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Infectious Disease Medicine; Isoniazid; Linezolid; Mycobacterium tuberculosis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization

2017
Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum.
    The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3

    Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Clofazimine; Cycloserine; Deprescriptions; Diarylquinolines; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Kanamycin; Linezolid; Neural Conduction; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Pyrazinamide; Pyridoxine; Tuberculosis, Pulmonary

2020